The natural history of white-coat hypertension in the long term

Blood Pressure Monitoring

Volumn 10, Issue 2, 2005, Pages 65-66

  Verdecchia, Paolo ^a   Angeli, Fabio ^a  

^a Ospedale Silvestrini   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; EDITORIAL; FOLLOW UP; HEART LEFT VENTRICLE MASS; HUMAN; PRIORITY JOURNAL; STROKE; SYSTOLIC BLOOD PRESSURE; WHITE COAT HYPERTENSION;

BLOOD PRESSURE DETERMINATION; HUMANS; HYPERTENSION; PHYSICIANS' OFFICES;

EID: 17844376497     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126097-200504000-00002     Document Type: Editorial

References (17)

1. Moser M. White-coat hypertension-to treat or not to treat. A clinical dilemma. Arch Intern Med 2001; 161:2055-2056.
2. Verdecchia P, O'Brien E, Pickering T, Staessen JA, Parati G, Myers M, et al. European Society of Hypertension Working Group on Blood Pressure Monitoring. When can the practicing physician suspect white coat hypertension? Statement from the Working Group on Blood Pressure Monitoring of the European Society of Hypertension. Am J Hypertens 2003; 16:87-91.
3. CMS. Centers for Medicare, & Medicaid Services. Medicare Coverage Policy ∼ Decisions. Ambulatory Blood Pressure Monitoring (#CAG-00067N). 2001. http://www.hcfa.gov/coverage/8b3-ff.htm.
4. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Porcellati C. White-coat hypertension. Lancet 1996; 348:1444-1445.
5. Kario K, Shimada K, Schwartz JE, Matsuo T, Hoshide S, Pickering TG. Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension. J Am Coll Cardiol 2001; 38:238-245.
6. Owens PE, Lyons SP, Rodriguez SA, O'Brien ET. Is elevation of clinic blood pressure in patients with white coat hypertension who have normal ambulatory blood pressure associated with target organ changes? J Human Hypertens 1998; 12:743-748.
7. Owens P, Atkins N, O'Brien E. Diagnosis of white coat hypertension by ambulatory blood pressure monitoring. Hypertension 1999; 34:267-262.
8. Fagard RH, Staessen JA, Thijs L, Gasowski J, Bulpitt CJ, Clement D, et al. Response to antihypertensive therapy in older patients with sustained and non-sustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation 2000; 102:1139-1144.
9. Grandi AM, Broggi R, Colombo S, Santillo R, Imperiale D, Bertolini A, et al. Left ventricular changes in isolated office hypertension. A blood pressure-matched comparison with normotension and sustained hypertension. Arch Intern Med 2001; 161:2677-2681.
10. Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R, et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation 2001; 104:1385-1392.
11. Palatini P, Mormino P, Santonastaso M, Mos L, Dal Folio M, Zanata G, et al. Target-organ damage in stage I hypertensive subjects with white coat and sustained hypertension: results from the HARVEST study. Hypertension 1998; 31:57-63.
12. Gustavsen PH, Hoeghoim A, Bang LE, Kristensen KS. White coat hypertension is a cardiovascular risk factor: A 10-year follow-up study. J Hum Hypertens 2003; 17:811-817.
13. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Sacchi N, et al. Identification of subjects with white-coat hypertension and persistently normal ambulatory blood pressure. Blood Press Monit 1996; 1:217-222.
14. Bidlingmeyer I, Burnier M, Bidlingmeyer M, Waeber B, Brunner HR. Isolated office hypertension: a prehypertensive state? J Hypertens 1996; 14: 327-332.
15. Polonia JJ, Santos AR, Gama GM, Basto F, Bettencourt PM, Martins LR. Follow-up clinic and ambulatory blood pressure in untreated white-coat hypertensive patients (evaluation after 2-5 years). Blood Press Monit 1997; 2:289-295.
16. Polónia JJ, Gama JM, Silva JA, Amaral C, Martins LR, Bertoquini SE. Sequential follow-up clinical and ambulatory blood pressure evaluation in a low risk population of white-coat hypertensive patients and in normotensives. Blood Press Monit 2005; 10.
17. Verdecchia P, Reboldi GP, Angeli F, Schillaci G, Schwartz JE, Pickering TG, et al. Short- and long-term incidence of stroke in white-coat hypertension. Hypertension 2005; 45(2);203-208.